Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).

@article{Kawano2015ClinicalFA,
  title={Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).},
  author={Noriaki Kawano and Shuro Yoshida and Takuro Kuriyama and Yoshihiro Tahara and Kiyoshi Yamashita and Yuri Nagahiro and Jiro Kawano and Hideki Koketsu and Atsushi Toyofuku and Tatsuya Manabe and Kiichiro Beppu and Nobuyuki Ono and Daisuke Himeji and Naoko Yokota-Ikeda and Sanshiro Inoue and Hidenobu Ochiai and Koh-Hei Sonoda and Kazuya Shimoda and Fumihiko Ishikawa and Akira Ueda},
  journal={Internal medicine},
  year={2015},
  volume={54 12},
  pages={1489-98}
}
OBJECTIVE Despite the remarkable advances in chemotherapy and allogeneic hematopoietic stem cell transplantation (HSCT), adult T-cell leukemia-lymphoma (ATL) is still associated with a high mortality rate. It is therefore essential to elucidate the current features of ATL. METHODS We retrospectively analyzed 81 patients with aggressive type ATL at our institution over a 7-year period based on Shimoyama's diagnostic criteria. RESULTS Eighty-one patients with a median age of 67.5 years were… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS